Eesti - eesti - Ravimiamet

csl behring gmbh - marutõve immunoglobuliin - süstelahus süstlis - 150rÜ 1ml 2ml 1tk

Eesti - eesti - Ravimiamet

bharat serums and vaccine limited - hobuse anti-t-lümfotsüütne immunoglobuliin - infusioonilahus - 50mg 1ml 5ml 1tk

Eesti - eesti - Ravimiamet

sanofi pasteur - marutõve koguviirus, inaktiveeritud - süstesuspensiooni pulber ja lahusti - 1annus 10tk; 1annus 1tk; 1annus 5tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosupressandid - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Euroopa Liit - eesti - EMA (European Medicines Agency)

amgen europe b.v. - romiplostiim - idiopaatiline, trombotsütopeeniline purpur - antihemorraagilised ained - adults:nplate is indicated for the treatment of primary immune thrombocytopenia  (itp) in adult patients who are refractory to other treatments (e. kortikosteroidid, immunoglobuliinid). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. kortikosteroidid, immunoglobuliinid).

Eesti - eesti - Ravimiamet

sanofi pasteur s.a. - teetanuse toksoid - süstesuspensioon - 40rÜ 0.5ml 20tk; 40rÜ 0.5ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - immunosupressandid - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.

Euroopa Liit - eesti - EMA (European Medicines Agency)

biokema anstalt - e. coli f5 (k99) adhesiini sisaldavate veiste kontsentreeritud laktoserum, mis sisaldab spetsiifilisi immunoglobuliine g - loomataimede immunoloogilised omadused - vasikad, vastsündinud alla 12-aastased - e-ga seotud enterotoksikoosi põhjustatud suremuse vähendamine. coli f5 (k99) adhesiini esimeste elupäevadel täiskasvanutena tampooni ternespiimast.

Eesti - eesti - Ravimiamet

merck sharp & dohme b.v. - tuulerõugete viirus, elus, nõrgestatud - süstesuspensiooni pulber ja lahusti süstlis - 1annus 0.5ml 0.5ml 1tk; 0.5ml 10tk; 0.5ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - immunosupressandid - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.